Aduhelm

For the past few months, Medicare officials have been inundated with impassioned pleas about how to handle coverage of the…

Medicare officials have decided that the federal health insurance program should only cover the controversial new Alzheimer’s drug Aduhelm for…

Federal officials are wrestling with a decision that could go a long way toward determining the future of the controversial…

Biogen slashed the price of its controversial new Alzheimer’s drug Aduhelm on Monday as the drug faces weak sales and…

Concerns about safety risks of the controversial new Alzheimer’s drug Aduhelm have intensified in the wake of the death of…